Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study

BACKGROUND: When type 2 diabetes is suboptimally controlled with basal insulin, prandial insulin injections are commonly added (i.e., a basal-bolus insulin regimen), which can increase treatment burden and hypoglycemia risk. The once-daily injectable iGlarLixi is an alternative treatment. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantalone, Kevin M., Heller, Caroline, Lajara, Rosemarie, Lew, Elisheva, Li, Xuan, Dex, Terry, Kilpatrick, C. Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425231/
https://www.ncbi.nlm.nih.gov/pubmed/37583559
http://dx.doi.org/10.2337/ds22-0064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425231/
https://www.ncbi.nlm.nih.gov/pubmed/37583559
http://dx.doi.org/10.2337/ds22-0064

Ejemplares similares